Cargando…
Identification and pharmaceutical evaluation of novel frog skin-derived serine proteinase inhibitor peptide–PE-BBI (Pelophylax esculentus Bowman-Birk inhibitor) for the potential treatment of cancer
Amphibian venom-derived peptides have high potential in the field of anticancer drug discovery. We have isolated a novel Bowman-Birk proteinase inhibitor (BBI)-type peptide from the skin secretion of Pelophylax esculentus (PE) named PE-BBI, and evaluated its bio-functions and anti-cancer activity in...
Autores principales: | Lyu, Peng, Ge, Lilin, Ma, Rui, Wei, Ran, McCrudden, Cian M., Chen, Tianbao, Shaw, Chris, Kwok, Hang Fai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6162207/ https://www.ncbi.nlm.nih.gov/pubmed/30267012 http://dx.doi.org/10.1038/s41598-018-32947-5 |
Ejemplares similares
-
Soybean-derived Bowman-Birk Inhibitor (BBI) Inhibits HIV Replication in Macrophages
por: Ma, Tong-Cui, et al.
Publicado: (2016) -
Corrigendum: Soybean-derived Bowman-Birk Inhibitor (BBI) Inhibits HIV Replication in Macrophages
por: Ma, Tong-Cui, et al.
Publicado: (2016) -
Ranacyclin-NF, a Novel Bowman–Birk Type Protease Inhibitor from the Skin Secretion of the East Asian Frog, Pelophylax nigromaculatus
por: Wang, Tao, et al.
Publicado: (2020) -
Identification and Target-Modification of SL-BBI: A Novel Bowman–Birk Type Trypsin Inhibitor from Sylvirana latouchii
por: Chen, Xi, et al.
Publicado: (2020) -
Discovery and Rational Design of a Novel Bowman-Birk Related Protease Inhibitor
por: Miao, Yuxi, et al.
Publicado: (2019)